RELAPSING-REMITTING MULTIPLE SCLEROSIS
Clinical trials for RELAPSING-REMITTING MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING-REMITTING MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two-Year watch: how safe is this MS injection?
Disease control CompletedThis study monitored patients with relapsing or progressive multiple sclerosis (MS) who were taking Kesimpta injections for two years. The main goal was to track side effects and see how well the drug worked at preventing relapses and slowing disability. Researchers followed 367 …
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New MS pill tested as add-on therapy in major trial
Disease control CompletedThis study tested whether adding an oral medication called PIPE-307 to existing multiple sclerosis treatments could help control the disease. About 182 adults with relapsing-remitting MS took either one of two doses of PIPE-307 or a placebo pill for about 30 weeks. Researchers me…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Virtual supermarket and driving simulator used to spot hidden MS brain fog
Knowledge-focused CompletedThis study tested whether virtual reality (VR) tasks, like navigating a virtual supermarket or using a driving simulator, are better than standard paper-and-pencil tests at detecting attention and thinking problems in people with relapsing-remitting multiple sclerosis (MS). Resea…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Did COVID-19 lockdowns disrupt MS relapse care? study investigates
Knowledge-focused CompletedThis study looked back to see if the first wave of the COVID-19 pandemic changed how people with multiple sclerosis (MS) reported and received care for their symptom flare-ups (relapses). Researchers compared 51 patients who had a relapse during April-June 2020 with a similar gro…
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Scientists hunt for clues in mysterious MS cases
Knowledge-focused CompletedThis study aimed to understand if people with unusual forms of multiple sclerosis (MS) have a different or more severe disease process. Researchers compared blood levels of specific proteins (neurofilament light chain and GFAP) in 15 patients with atypical MS to 30 patients with …
Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC